-
12.04.2013
Transformative healthcare - 2013 is a big year for Hermo Pharma
Read more
-
15.03.2013
Hermo Pharma a Finalist for the 2013 Red Herring Top 100 Europe Award
Read more
-
07.03.2013
CDNF patent granted in Japan
Read more
-
05.02.2013
Last patients completed treatment in amblyopia phase 2a clinical study
Read more
-
23.01.2013
CDNF patent granted in Australia
Read more
-
18.01.2013
Selection among Top 20 startup companies in Finland
Read more
-
14.11.2012
Update in the R&D pipeline
Read more
-
14.11.2012
Patient recruitment completed for HER-801 phase 2a clinical study
Read more
-
29.10.2012
Modulation of neuronal plasticity to treat neurodevelopmental disorders in adulthood
Read more
-
01.10.2012
Hermo Pharma a finalist in Rising Star Award competition
Read more
-
18.09.2012
Meet us at the Biotech in Europe Investor Forum or Biopartnering FutureEUROPE
Read more
-
07.08.2012
Meet us at the Nordic Congress of Ophthalmology in Helsinki
Read more
-
11.06.2012
Meet us at BIO 2012 in Boston
Read more
-
04.05.2012
Meet us at BioEquity Europe 2012 Frankfurt
Read more
-
24.04.2012
Jonathan Knowles invests in Hermo Pharma's Series A round
Read more
-
09.12.2011
Hermo Pharma selected as one of the 30 most promising Finnish growth companies
Read more
-
29.08.2011
Tekes grants Hermo Pharma funding for clinical development of Amblyopia in adults Therapy
Read more
-
29.08.2011
Michael J. Fox Foundation awards additional $188,818 to professor Mart Saarma for therapeutic development for Parkinson’s disease
Read more
-
15.08.2011
Sigrid Booms joins Hermo Pharma as Director of Clinical Development
Read more
-
24.05.2011
Position available for Director of Clinical Development
Read more
-
21.04.2011
Hermo Pharma closes first industrial partnership agreement with major pharmaceutical company
Read more
-
17.03.2011
CTA approval for HER-801 phase 2a study
Read more
-
07.03.2011
Meet us at BIO-Europe Spring in Milan
Read more
-
09.02.2011
Tekes grants funding for preclinical development of CDNF for Parkinson's disease
Read more
-
27.01.2011
Clinical Trial Application for adult amblyopia filed
Read more
-
16.12.2010
Mart Saarma nominated in EMBO Council
Read more
-
09.12.2010
Hermo Pharma at Bio-Europe 2010
Read more
-
03.12.2010
Pekka Männistö Receives Honorary Doctorate
Read more
-
09.11.2010
Jonathan Knowles receives Scrip Lifetime Achievement Award 2010
Read more
-
06.10.2010
Michael J. Fox Foundation awards a grant to support development of CDNF
Read more
-
05.10.2010
CDNF EPO patent granted to Hermo Pharma
Read more
-
05.10.2010
Growth mentoring by Culminatum Innovation
Read more
-
11.08.2010
Hermo Pharma acquires rights to the CDNF technology
Read more
-
01.04.2010
Tekes grants Hermo Pharma funding for preclinical development of HER-801
Read more
-
01.03.2010
Hermo Pharma selected in Tekes' Pharma Business and Marketing Mentoring Program
Read more
-
11.02.2010
Tekes awards Hermo Pharma a grant for business development
Read more
-
03.01.2010
Hermo Pharma Ltd. announces appointments for Board of Directors
Read more
-
16.12.2009
Hermo Pharma Ltd. closes first round of financing
Read more
-
15.12.2009
Executive management nominations
Read more
-
05.05.2009
Tekes awards Hermo Pharma a grant for initiation of business activities
Read more
|
